Artificial intelligence in bladder cancer:current trends and future possibilities  

作　　者：Jun Ma Deep K.Vaishnani Rixu Lin Jiayu Lyu Bingyan Ni Yang Zhang Mengjun Hu Guorong Chen 

机构地区：[1]Department of Pathology,First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China [2]School of International Studies,Wenzhou Medical University,Wenzhou,Zhejiang 325035,China [3]Department of Psychiatry,The Affiliated Kangning Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China [4]School of Clinical Medicine,Wenzhou Medical University,Wenzhou,Zhejiang 325035,China [5]Department of Pathology,Zhuji People’s Hospital,Shaoxing,Zhejiang 311800,China

出　　处：《Chinese Medical Journal》2022年第7期881-882,共2页中华医学杂志（英文版）

基　　金：the Zhejiang Provincial Medical and Health Science and Technology(No.WKJ-ZJ-1929)。

摘　　要：To the Editor:Bladder cancer is the most common malignant tumor of the urinary system in the Asian population.In China,it is reported 80,000 new cases each year with an increasing incidence every year.Among these cases,75%are of non-muscle invasive bladder cancer(NMIBC).In muscular invasive bladder cancer(MIBC)and NMIBC patients,radical cystectomy is considered as a primary approach of treatment due to the higher risk of tumor progression.Furthermore.

关 键 词：BLADDER CANCER URINARY 

分 类 号：R737.14[医药卫生—肿瘤] TP18[医药卫生—临床医学]